Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Page Options
E-Mail This Search
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
or
LiveHelp online chat
Quick Links
Help Using the NCI Clinical Trials Search Form
Educational Materials About Clinical Trials
About NCI's Cancer Clinical Trials Registry
Dictionary of Cancer Terms
NCI Drug Dictionary
View Content for:
Patients
Health Professionals
Display:
Title
Description with:
Locations
Eligibility
Full Trial Description
Custom
Results 1-14 of 14 for your search:
Drug:
anguidine
Find trials that include:
Any drugs shown
Trial Status:
Closed
Hide Search Criteria
Show Search Criteria
Help with Results
Select All on Page
Sort by:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Show
10
25
50
100
200
Results per Page
1.
Phase I/II Evaluation of ANG Modification of 5-FU and MITO Toxicity for Unresectable Colorectal and Refractory Gastric Cancer
Phase:
Phase II, Phase I
Type:
Treatment
Status:
Closed
Age:
no age specified
Sponsor:
Protocol IDs:
MDA-DM-8204
2.
Phase II Chemotherapy with Anguidine for Refractory Stage IV Breast Carcinoma
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
no age specified
Sponsor:
Protocol IDs:
MDA-MBDT-7801
3.
Phase II Chemotherapy with Anguidine for Pediatric and Adolescent Acute Lymphoblastic Leukemia in Relapse
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
under 21
Sponsor:
NCI
Protocol IDs:
POG-7810
4.
Phase II Chemotherapy with Cyclic Daily Anguidine for Gastrointestinal Tract Adenocarcinoma
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
no age specified
Sponsor:
Protocol IDs:
SEG-77GI0202
, SEG-77GI221
5.
Phase II Study of Chemotherapy with Anguidine for Solid Tumors
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
18 and over
Sponsor:
Protocol IDs:
SEG-77ST219
, SEG-77ST0102
6.
Phase II Study of Anguidine Chemotherapy for Advanced Soft Tissue and Bony Sarcomas
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
no age specified
Sponsor:
NCI
Protocol IDs:
SWOG-7731
7.
Phase II Chemotherapy with Anguidine for Advanced Gastrointestinal Malignancies
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
no age specified
Sponsor:
NCI
Protocol IDs:
SWOG-7735
8.
Phase II Chemotherapy with Anguidine for Urological Malignancies
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
no age specified
Sponsor:
NCI
Protocol IDs:
SWOG-7736
9.
Phase II-Pilot Chemotherapy with Anguidine for Acute Nonlymphocytic Leukemia Refractory to Standard Therapy
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
over 21
Sponsor:
NCI
Protocol IDs:
SWOG-8063
10.
Pilot Phase II Study with Anguidine to Prevent Myelosuppression in Patients with Leukemia and Solid Tumors Treated with ARA-C
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
no age specified
Sponsor:
Protocol IDs:
MDA-DT-7977P
11.
Phase II Chemotherapy with Anguidine for Adenocarcinoma of the Colon
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
no age specified
Sponsor:
Protocol IDs:
MDA-DT-7707
12.
Phase I Chemotherapy with Anguidine for Solid Tumors and Hematologic Malignancies
Phase:
Phase I
Type:
Treatment
Status:
Closed
Age:
no age specified
Sponsor:
Protocol IDs:
MDA-DT-7436
13.
Chemotherapy with Anguidine for CNS Tumors in Children
Phase:
No phase specified
Type:
Treatment
Status:
Closed
Age:
under 21
Sponsor:
NCI
Protocol IDs:
POG-7812
, MDAR-292
14.
Combination Chemotherapy with 5-FU and Anguidine for Advanced Colorectal Adenocarcinoma
Phase:
No phase specified
Type:
Treatment
Status:
Closed
Age:
no age specified
Sponsor:
Protocol IDs:
MDA-DT-7702
Select All on Page
Help with Results
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute